The menopausal transition alters brain circuitry and estrogen signaling in ways that may elevate risk for Alzheimer disease.
Carolyn Fredericks, MD
Advertisement
Articles by Carolyn Fredericks, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
New CKD Outcome Set Tells Pharmacists What to Measure
2
FDA Approves Zilganersen Injection, First Drug for Alexander Disease
3
AAP Issues 2026-2027 Guidance on RSV and COVID-19 Immunization
4
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
5